Epinastine Hydrochloride Solution/ Drops
Product Images NDC 70069-008

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Epinastine Hydrochloride (NDC 70069-008). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Somerset Therapeutics, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

775198aa 738b 4d22 813a 4c22e4ff750d 01

Chemical structure diagram of epinastine hydrochloride, showing the molecular framework including fused rings and attached functional groups with a notation for the hydrochloride (HCl) component.*

FDA Label Image

775198aa 738b 4d22 813a 4c22e4ff750d 02

Label for Epinastine HCl Ophthalmic Solution 0.05%, a 5 mL sterile eye drop solution containing epinastine hydrochloride 0.5 mg/mL (0.05%) plus benzalkonium chloride preservative. Manufactured for Somerset Therapeutics, LLC, Hollywood, FL, with barcode and storage instructions included.*

FDA Label Image

775198aa 738b 4d22 813a 4c22e4ff750d 03

Packaging label for Epinastine HCI Ophthalmic Solution 0.05% sterile solution, 5 mL bottle, manufactured by Somerset Therapeutics LLC. The label includes active ingredient and preservative details, usage instructions, storage conditions, and a note that the package is not child resistant.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.